Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK7 | Q13164 | 8/20 | 0.56 |
| ▸ | BRD4 | O60885 | 6/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.45 |
| ▸ | PRKDC | P78527 | 1/20 | 0.45 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | TTK | P33981 | 1/20 | 0.43 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.43 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.41 |
| ▸ | AURKA | O14965 | 3/20 | 0.41 |
| ▸ | PIK3C2G | O75747 | 3/20 | 0.41 |
| ▸ | PIK3CG | P48736 | 3/20 | 0.41 |
| ▸ | AURKB | Q96GD4 | 3/20 | 0.41 |
| ▸ | DCLK1 | O15075 | 4/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.40 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18369886 | 0.87 | MAPK7 (0.57) | MAPK7BRD4KCNH2PIK3CAPRKDC | |
| SCHEMBL18369845 | 0.84 | MAPK7 (0.54) | MAPK7BRD4KCNH2PIK3CATTK | |
| SCHEMBL18369841 | 0.82 | MAPK7 (0.61) | MAPK7BRD4KCNH2CCNA2CDK2 | |
| SCHEMBL18369826 | 0.82 | MAPK7 (0.54) | MAPK7BRD4KCNH2PIK3CAPRKDC | |
| SCHEMBL18369884 | 0.82 | MAPK7 (0.54) | MAPK7BRD4KCNH2TTKPIK3CD | |
| SCHEMBL18369848 | 0.81 | MAPK7 (0.53) | MAPK7BRD4KCNH2PIK3CDAURKA | |
| SCHEMBL18369936 | 0.80 | MAPK7 (0.61) | MAPK7BRD4KCNH2DCLK1LRRK2 | |
| SCHEMBL18369863 | 0.80 | MAPK7 (0.55) | MAPK7BRD4KCNH2PIK3CAPRKDC | |
| SCHEMBL18370090 | 0.80 | MAPK7 (0.50) | MAPK7BRD4KCNH2PIK3CDAURKA | |
| SCHEMBL17059912 | 0.79 | MAPK7 (0.52) | MAPK7BRD4KCNH2PIK3CAPRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170008888-A1 | HETEROCYCLIC COMPOUNDS | ACTIVX BIOSCIENCES, INC. | 2017-01-12 | — | — | US | disclosed |
| US-20170008888-A1 | HETEROCYCLIC COMPOUNDS | ACTIVX BIOSCIENCES, INC. | 2017-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170008888-A1 | HETEROCYCLIC COMPOUNDS | BET1, EP300, RBBP5 | MAPK7 58/4885BRD4 4/4885KCNH2 4491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.